Heart Disease Trial, Recruiting NCT07055152 Sponsor: University of Pisa Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT07055152
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be over 18 years old.
  • You may be eligible if you have been diagnosed with a heart attack where the coronary arteries were found to be mostly clear (not blocked), confirmed by a special X-ray procedure of the heart's arteries.
  • You may be eligible if you have been diagnosed with a serious heart condition caused by blocked coronary arteries, and you match certain characteristics with another group of patients in the study (confirm with trial site).
  • You may be eligible as a healthy volunteer if you have no history of heart or blood vessel disease, and you are a similar age and gender to other participants.
  • You must be willing and able to sign a written consent form agreeing to take part.
  • You must be able to undergo a special eye-scanning procedure (called OCTA) and other required imaging tests.

Who may not be able to join:

  • You may not be able to join if you have a significant eye condition, such as glaucoma, diabetic eye disease, or macular degeneration, that could affect the quality of the eye scan.
  • You may not be able to join if you have a serious ongoing illness such as advanced kidney failure, active cancer, or severe liver disease.
  • If you are in the "clear arteries" heart attack group, you may not be able to join if your coronary arteries are found to be more than 50% blocked, or if a specific heart test shows a significant blockage, or if a scan shows signs of heart muscle inflammation (confirm with trial site).
  • You may not be able to join if you are currently pregnant or breastfeeding.
  • You may not be able to join if you are unable or unwilling to attend follow-up visits and complete all study procedures.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +393271946335

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Pisa
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
1 January 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

OCTA changes in three different courts and their correlation with clinical and imaging biomarkers

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov